B. Braun, which owns shares in Germany-based hospital operator Rhoen-Klinikum is upping its stake in Rhoen to 25 percent in efforts to prevent a buyout of Rhoen by B. Braun rival Fresenius.
The move closely follows last year’s efforts, which saw B. Braun acquire five percent in Rhoen to prevent Fresenius’s agenda of becoming the nation’s largest private hospital operator. B. Braun and Fresenius are rivals in the healthcare equipment market.
Both B. Braun and hospital operator Asklepios – which also holds shares in Rhoen – were reportedly concerned that a buyout by Fresenius would reduce competition in the market. In a statement released Tuesday, B. Braun said it “remains committed to sustainably secure the minority shareholding position” in Rhoen.
The acquisition remains subject to regulatory approval.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Nvidia and Microsoft Sued for Allegedly Undercutting AI Technology Patent Prices
Sep 5, 2024 by
CPI
White & Case Strengthens Antitrust and M&A Practices with New Partner Additions
Sep 5, 2024 by
CPI
Federal Judge Dismisses Antitrust Lawyers’ Fee Demand Over JetBlue-Spirit Deal
Sep 5, 2024 by
CPI
Boston Landlords Named as US Sues RealPage Over Alleged Rent-Inflating Practices
Sep 5, 2024 by
CPI
Judge to Weigh Landmark NCAA Settlement Proposal in Antitrust Lawsuit
Sep 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI